Lighthouse manufacturing techniques utilize technology and automation to streamline production.
Prior to the COVID-19 pandemic, the bio/pharma manufacturing industry had been relatively slow to embrace the ongoing digital revolution. But the pandemic forced the life sciences industry and drug developers to rethink their hesitation toward digitization to quickly produce and distribute new vaccines under unprecedented conditions. Now, technology is being used as a solution to improve efficiency and sustainability in life sciences manufacturing. Those who have led the way are said to be creating the “lighthouse effect.” Just as actual lighthouses help sailors navigate dangerous waters, lighthouse companies serve as guiding lights for charting the course of an entire industry. For the life sciences manufacturing industry, becoming one of these luminaries relies on a mix of advanced technical capabilities and coming up with innovative applications for the technology. In the age of Big Data, artificial intelligence (AI) and digitization will play lead roles in achieving lighthouse effects.
Read this article in the Trends in Manufacturing ebook.
1. World Economic Forum and McKinsey & Company, “Global Lighthouse Network: Reimagining Operations for Growth,” Whitepaper, 2021.
2. C. Schmidt, “Machine Learning Poised to Accelerate Drug Discovery,” Novartis, May 7, 2018
Gul Dusi is a director for Linesight.
Pharmaceutical Technology
eBook: Trends in Manufacturing
May 2022
Pages: 60-62
When referring to this article, please cite it as G. Dusi, “The Lighthouse Effect: Using Technology to Improve Life Sciences Manufacturing,” Pharmaceutical Technology Trends in Manufacturing eBook (May 2022).
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.